Fate Therapeutics Inc FATE:NASDAQ

Last Price$15.60Cboe Previous Close - Real-Time Last Sale as of 4:00PM ET 4/17/19
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$15.00 (300)
Ask (Size)$16.44 (100)
Day Low / HighN/A - N/A
Volume25.00
View:
Values are displayed in MillionsTrend
12/31/2015

12/31/2016

12/31/2017

12/31/2018
Net Revenues
2445
Depreciation And Amortization
0.690.880.971
General Expenses
30354571
Research And Development
19263355
Total Operating Expenses
30364672
Operating Income
-28-32-42-67
Extraordinary Charge
00-0.120
Interest Expense On Debt
2212
Pre-Tax Income
-30-33-43-67
Net Income Before Preferreds and Extraordinary Items
-30-33-43-67
Preferred Dividend
0N/AN/AN/A
Income Available for Common
-30-33-43-67
Shares To Calculate EPS
25324256
Shares To Calculate EPS Diluted
25324256
EPS
-1.18-1.05-1.02-1.19
EPS Diluted
-1.18-1.05-1.02-1.19
 

SEC Filings

Filing TypeFiling CategoryFiling Date
DEFA14AProxy Statement04/08/2019
4Insider Buy/Sell03/29/2019
4Insider Buy/Sell03/22/2019
DEF 14AProxy Statement03/22/2019
8-KCompany Events03/18/2019
3New Insider03/18/2019
4Insider Buy/Sell03/18/2019
S-8Employee Benefit Plan Registration03/08/2019
4Insider Buy/Sell03/05/2019
8-KCompany Events03/05/2019
10-KAnnual Financials03/05/2019
4Insider Buy/Sell02/27/2019
CT ORDERCT ORDER02/27/2019
SC 13G/A>= 5% Acquisition02/13/2019
SC 13G>= 5% Acquisition02/08/2019
10-Q/AQuarterly Financials02/08/2019
4Insider Buy/Sell02/01/2019
4Insider Buy/Sell01/31/2019
4Insider Buy/Sell01/30/2019
4Insider Buy/Sell01/29/2019